HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Knockdown of MAP4 and DNAL1 produces a post-fusion and pre-nuclear translocation impairment in HIV-1 replication.

Abstract
DNAL1 and MAP4 are both microtubule-associated proteins. These proteins were identified as HIV-1 dependency factors in a screen with wild-type HIV-1. In this study we demonstrate that knockdown using DNAL1 and MAP4 siRNAs and shRNAs inhibits HIV-1 infection regardless of envelope. Using a fusion assay, we show that DNAL1 and MAP4 do not impact fusion. By assaying for late reverse transcripts and 2-LTR circles, we show that DNAL1 and MAP4 inhibit both by approximately 50%. These results demonstrate that DNAL1 and MAP4 impact reverse transcription but not nuclear translocation. DNAL1 and MAP4 knockdown cells do not display cytoskeletal defects. Together these experiments indicate that DNAL1 and MAP4 may exert their functions in the HIV life cycle at reverse transcription, prior to nuclear translocation.
AuthorsDaniel E Gallo, Thomas J Hope
JournalVirology (Virology) Vol. 422 Issue 1 Pg. 13-21 (Jan 05 2012) ISSN: 1096-0341 [Electronic] United States
PMID22018492 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • DNAL1 protein, human
  • Microtubule-Associated Proteins
  • RNA, Small Interfering
  • RNA, Viral
Topics
  • Cell Line
  • Cell Nucleus (metabolism, virology)
  • Cytoskeleton (genetics, metabolism, virology)
  • HIV Infections (genetics)
  • HIV Long Terminal Repeat (genetics)
  • HIV-1 (genetics, metabolism, physiology)
  • HeLa Cells
  • Humans
  • Microtubule-Associated Proteins (genetics, metabolism)
  • Microtubules (metabolism)
  • Protein Transport
  • RNA Interference
  • RNA, Small Interfering
  • RNA, Viral
  • Reverse Transcription
  • Virus Internalization
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: